K. . Khan, “Pioglitazone for Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Patients with or at High Risk of Type 2 Diabetes: A Meta-Analysis”, IJMBS, vol. 9, no. 1, pp. 259–264, Feb. 2025.